ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Sanofi

Sanofi (1SAN)

90.50
0.00
( 0.00% )
Updated: 03:10:45

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
90.50
Bid
90.73
Ask
90.82
Volume
0.00
0.00 Day's Range 0.00
80.75 52 Week Range 104.22
Market Cap
Previous Close
90.50
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
889
Shares Outstanding
1,252,640,466
Dividend Yield
4.15%
PE Ratio
20.98
Earnings Per Share (EPS)
4.31
Revenue
43.07B
Net Profit
5.4B

About Sanofi

Sector
Health & Allied Services,nec
Industry
Pharmaceutical Preparations
Website
Headquarters
Paris, Paris, Fra
Founded
1994
Sanofi is listed in the Health & Allied Services sector of the Italian Stock Exchange with ticker 1SAN. The last closing price for Sanofi was 90.50 €. Over the last year, Sanofi shares have traded in a share price range of 80.75 € to 104.22 €.

Sanofi currently has 1,252,640,466 shares outstanding. The market capitalization of Sanofi is 113.29 € billion. Sanofi has a price to earnings ratio (PE ratio) of 20.98.

1SAN Latest News

Communiqué de presse : Dupixent devient le tout premier médicament ciblé pour le traitement de la BPCO approuvé dans l’Union européenne

Communiqué de presse : Dupixent devient le tout premier médicament ciblé pour le traitement de la BPCO approuvé dans l’Union européenne Dupixent devient le tout premier médicament ciblé pour...

Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM

Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM Dupixent positive phase 3 data in children one to 11 years of...

Press Release: Availability of the Q2 2024 Aide-mémoire

Press Release: Availability of the Q2 2024 Aide-mémoire Availability of the Q2 2024 Aide-mémoire Paris, France – June 25, 2024. Sanofi announced that its Q2 2024 Aide-mémoire is available on...

Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee

Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee Audrey Duval Derveloy appointed Global Head of Corporate Affairs...

Press Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran

Press Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and...

Communiqué de presse : Sanofi et Biovac pionniers de la production de vaccins contre la polio en Afrique

Communiqué de presse : Sanofi et Biovac pionniers de la production de vaccins contre la polio en Afrique Sanofi et Biovac pionniers de la production de vaccins contre la polio en Afrique...

Sanofi: Information concerning the total number of voting rights and shares – May 2024

Sanofi: Information concerning the total number of voting rights and shares – May 2024 Information concerning the total number of voting rights and shares, provided pursuant to article L...

Press Release: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3

Press Release: ASCO: Sarclisa is first anti-CD38 to significantly improve progression-free survival in combination with VRd for newly diagnosed transplant-ineligible multiple myeloma in phase 3...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.59-1.726571831992.0992.3190.1578391.27460399DE
4-0.79-0.86537408259491.2992.3186.261389.92006603DE
1233.4285714285787.594.4585.1488990.05394707DE
26-1.5-1.630434782619296.4684.9880989.87661585DE
52-7.84-7.9723408582598.34104.2280.7576089.95447451DE
1562.663.0282331511887.84106.0676.36107889.85325537DE
26012.516.025641025678106.0668154386.89657875DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AAGRAfrican Agriculture Holdings Inc
$ 0.201
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 61.42
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.32
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.44
(0.00%)
0
AACGATA Creativity Global
$ 0.8248
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.201
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 61.42
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.32
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.44
(0.00%)
0
AACGATA Creativity Global
$ 0.8248
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.201
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 61.42
(0.00%)
0
AADIAadi Bioscience Inc
$ 1.32
(0.00%)
0
AACIArmada Acquisition Corporation I
$ 11.44
(0.00%)
0
AACGATA Creativity Global
$ 0.8248
(0.00%)
0

Discussion

View Full Feed
gitreal gitreal 4 minutes ago
Were you a Moderator, and recently got removed? Your sticky would have been removed as well.

Also, I can only sticky a post if it is less than 48 hours old. So, I stickied your post about the original post you wanted stickied.

If you want a better post with phone
STAL
TommyJ7651 TommyJ7651 10 minutes ago
New interview from Ron's basement with Dan. Nothing new in particular but he is still saying we will soon get a sort of "step by step" development plan for Duparquet. I am still of the opinion that Duparquet will be the project that will first get a partnership announcement simply because it will pr
FFMGF
moola26 moola26 23 minutes ago
Yup. No one giving up their shares. We all holding strong much to their dislike.
MAJORITY HOLDING STRONG$$$
joeycav11 joeycav11 23 minutes ago
Its interesting that Hiltonol/polyicl was not mentioned at the agm. And if you Google the query Hiltonol is it FDA approved it states
The supplied Hiltonol for use in commercial production and sale of any combination production will be completed grade and meet US FDA requirements for commerci
NWBO
Wise Man Wise Man 24 minutes ago
UPDATE. I've just read the amended complaint filed by the attorney D.Thompson with Wazee II in a district court on July 1st.
As expected, he not only doesn't challenge the ongoing NWS 2.0, but also he praises it the same way he did before: "FnF build capital at the same time the Treasury maxi
FNMA
Bob Mullet Bob Mullet 25 minutes ago
Jetoe, so what you are saying is, that you’ll be buying on the dip?

KBLB
JamesLH JamesLH 28 minutes ago
There you go calling everyone else a Clown and a Muppet, do you have ANYTHING to contribute except childish name calling? Or are words too much for you to comprehend? what does that make you Ricki?? LMFAO
RDGL
Mountainman5 Mountainman5 31 minutes ago
I AM DEFINITELY SURE - OPTT WILL BE THE NEW GAMESTOP 2024!!!!!!!!!!!!!!
OPTT
Mountainman5 Mountainman5 31 minutes ago
I AM DEFINITELY SURE - OPTT WILL BE THE NEW GAMESTOP 2024!!!!!!!!!!!!!!
OPTT
Mountainman5 Mountainman5 32 minutes ago
I AM DEFINITELY SURE - OPTT WILL BE THE NEW GAMESTOP 2024!!!!!!!!!!!!!!
OPTT
Mountainman5 Mountainman5 33 minutes ago
OPTT = SKYROCKETING 2024!!!!!!!!!!!!!
OPTT
ramalio ramalio 36 minutes ago
Ya getting more bizarre day by day, blondie!
"I'll hang around ..." LOL
What else? Job is job!
BMXI
nickmerck nickmerck 37 minutes ago
great news, that means insiders will finally be able to offload higher volumes! :)
RCAT
3Angels120702 3Angels120702 37 minutes ago
I've never seen Schlenk respond to anything so good luck. If this fails it's on him. He's never getting another shot like this one IMO. Maybe that's why the stock has been stuck for years...he just can't deliver in the end.
MWWC
Ranb2khz Ranb2khz 38 minutes ago
Failing to Listen to God

~ Accept and be thankful for godly correction; your life will be better because of it.

Scripture Reading: www.biblegateway.com/passage/?search=2%20Timothy%204%3A1-4&version=HCSB,KJV 2 Timothy 4:1-4

In his second letter to Timot
Mountainman5 Mountainman5 39 minutes ago
OPTT IS STIll TOTALLY UNDERVALUED!!!!!!!!!!
OPTT
Mountainman5 Mountainman5 39 minutes ago
OPTT IS STIll TOTALLY UNDERVALUED!!!!!!!!!!
OPTT
Mountainman5 Mountainman5 39 minutes ago
OPTT IS STIll TOTALLY UNDERVALUED!!!!!!!!!!
OPTT
Mountainman5 Mountainman5 40 minutes ago
$ 3 -$ 5 BY THE END OF THIS MONTH??????????
OPTT
stealofadeal stealofadeal 41 minutes ago
$BLTH Still very quiet
BLTH
Mountainman5 Mountainman5 42 minutes ago
IS OPTT THE NEW GAMESTOP??????????
OPTT
stealofadeal stealofadeal 44 minutes ago
$RDAR Where’s Golden Cross the company hired pumper? He give up finally?
RDAR

Your Recent History

Delayed Upgrade Clock